Collegium Pharmaceutical, Inc. (NASDAQ: COLL) announced the completion of its acquisition of AZSTARYS from Corium Therapeutics for approximately $650 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE